Drugs that target wakefulness, molecules in cannabis and wearable devices that modulate brain activity could help people with ...

Aurinia Pharmaceuticals Inc. (Aurinia or the Company), today announced that a post-hoc analysis of the 52-week, Phase 3 AURORA 1 study showed that lupus nephritis (LN) patients who received triple ...

A new study published in Neuropsychopharmacology provides preliminary evidence that amlodipine, a widely used medication for ...